Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Primary central nervous system lymphoma--a report of 32 cases with literature review]

[Primary central nervous system lymphoma--a report of 32 cases with literature review] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Primary central nervous system lymphoma--a report of 32 cases with literature review] Abstract Text:

    ji-qun yiJi-Qun Yi,tong-yu linTong-Yu Lin,you-jian heYou-Jian He,hui-qiang huangHui-Qiang Huang,zhong-jun xiaZhong-Jun Xia,yun-fei xiaYun-Fei Xia,rui-hua xuRui-Hua Xu,ying guoYing Guo,zhong-zhen guanZhong-Zhen Guan,

    BACKGROUND & OBJECTIVE: The incidence of primary central nervous system lymphoma (PCNSL) is increasing, and its prognosis is poor. This study was to investigate the clinical features of PCNSL, and evaluate the efficacy of high-dose methotrexate (MTX)-based chemotherapy for immunocompetent Chinese patients with PCNSL. METHODS: Clinical data of 32 patients (median age, 50 years) with pathologically confirmed PCNSL were analyzed retrospectively. Before Nov. 2001, CHOP with or without whole brain radiotherapy (WBRT) was employed; after then, high-dose MTX-based chemotherapy with or without WBRT was employed. RESULTS: Of the 32 PCNSL patients, 25 (78.1%) were more than 45 years old; 24 (75.0%) suffered intracranial hypertension; 25 (78.1%) had single intracranial mass; no positive case of cerebrospinal fluid (CSF) cellular examination was found; 28 (87.5%) were B-cell lymphoma, among which 19 (59.4%) were diffuse large B-cell lymphoma. Median follow-up of the patients was 13.5 months (1-84 months). Kaplan-Meier test showed that the median overall survival time was 26 months, and the 2-year survival rate was 45.7%. The complete response rate of the 18 patients who received high-dose MTX-based chemotherapy plus WBRT was 61.1%, the median survival time was more than 26 months, and the 2-year survival rate was 65.1%. The efficacy of high-dose MTX-based chemotherapy plus WBRT was better than that of CHOP plus WBRT. Log-rank test showed that the survival time of the patients with performance status (PS) of 0-1 or normal serum lactate dehydrogenase (LDH) was longer than those with PS of 2-3 or elevated LDH. CONCLUSIONS: PCNSL often occurs in middle-aged and aged patients, with intracranial hypertension as the main clinical manifestation. B-cell lymphoma is the predominant subtype. High-dose MTX-based chemotherapy plus WBRT is efficient and feasible for PCNSL.

    [Primary central nervous system lymphoma--a report of 32 cases with literature review] Publishing Authors By Initials

    jq yiJQ Yi,ty linTY Lin,yj heYJ He,hq huangHQ Huang,zj xiaZJ Xia,yf xiaYF Xia,rh xuRH Xu,y guoY Guo,zz guanZZ Guan,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Primary central nervous system lymphoma--a report of 32 cases with literature review] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Ai zheng = Aizheng = Chinese journal of cancer

    VOLUME: 25

    Page Numbers: 476-80

    Journal Abbreviation: Ai Zheng

    ISSN: 1000-467X

    DAY: 14

    MONTH: Apr

    YEAR: 2006

    [Primary central nervous system lymphoma--a report of 32 cases with literature review] Information

    Number of References:

    LANGUAGE: chi

    NlmUniqueID: 9424852

    [Primary central nervous system lymphoma--a report of 32 cases with literature review] Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: [Primary central nervous system lymphoma--a report of 32 cases with literature review] Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for [Primary central nervous system lymphoma--a report of 32 cases with literature review]

    AFFILIATION: State Key Laboratory of Oncology in South China, Guangzhou, Guangdong 510060, P. R. China.

    Country: China

    China Research PublicationChina Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ai Zheng

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Primary central nervous system lymphoma--a report of 32 cases with literature review Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News